Pfizer Sales Suffer From Patent Losses, Stronger Dollar |
| January 28, 2015 | January 2015 Bond Updates |
|
Pfizer reported a decline in fourth-quarter sales Tuesday, pointing to headwinds of a stronger dollar and competition from generic drugs as more patents expire, issues it says aren't likely to abate this year. |
| View more at: http://www.forbes.com/sites/laurengensler/2015/01/27/pfizer-sales-suffer-from-patent-losses-stronger-dollar/ |
| Related News |
|